GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (FRA:XN4) » Definitions » Total Equity

Big Pharma Split (FRA:XN4) Total Equity : €10.72 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Big Pharma Split Total Equity?

Big Pharma Split's total equity for the quarter that ended in Jun. 2024 was €10.72 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Big Pharma Split Total Equity Historical Data

The historical data trend for Big Pharma Split's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Total Equity Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial 11.15 8.46 15.49 13.71 10.83

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.68 13.71 12.13 10.83 10.72

Big Pharma Split Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Big Pharma Split's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=18.137-7.303
=10.83

Big Pharma Split's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=18.742-8.018
=10.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Big Pharma Split Total Equity Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (FRA:XN4) » Definitions » Total Equity
Comparable Companies
TSX:PWI TSXV:MONT TSX:XTD TSX:MDS.UN TSXV:FW TSXV:TORR TSX:MSRE.UN XCNQ:IDK TSXV:TIE XCNQ:SPLY BLK BX OSTO:INVE A TSX:BN KKR APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
PRM.PR.A.PFD:Canada PRM:Canada
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Website
https://www.harvestportfolios.com
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Big Pharma Split Headlines

No Headlines